Citizen Watch America Celebrates Opening of Fifth Avenue CITIZEN FLAGSHIP STORE NEW YORK
The premiere retail destination offers an immersive shopping experience with Accutron, Alpina, Bulova, Citizen, and Frederique Constant brands NEW YORK, Dec. 7, 2023 /PRNewswire/ — Citizen Watch America (CWA), a leader in accessible luxury timepieces, marked the official opening of the group&
Announcing the ‘Best Workplaces™ in Greater China 2023’ List. “Integrating ESG & AI at the Workplace”. By Great Place to Work®
SHANGHAI, Dec. 8, 2023 /PRNewswire/ — Validated by more than 120,000 employees, Great Place to Work® is recognizing the Best Workplaces™ in Greater China, for 2023. Within the framework of this year’s Conference topic: “Integrating ESG & AI at the Workplace”, organisa
SOLIRIS Drug Insight and Market Forecasts, 2019-2032: The First Therapy Approved to Treat Patients with PNH
DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “SOLIRIS Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about SOLIRIS for paroxysmal nocturnal hemoglobinuria (PNH) in the seven
FIII HONG KONG INVESTOR SUMMIT 7/8 DECEMBER BRINGS LEADERS TOGETHER TO ADDRESS HUMANITY’S BIGGEST CHALLENGES
RIYADH, Saudi Arabia, Dec. 7, 2023 /PRNewswire/ — The Future Investment Initiative PRIORITY Summit Hong Kong today convenes global investors, innovators and policymakers to tackle technology, climate, and economy threats. Investors and leaders from across Asia have gathered in Hong Kong with c
EV Group Brings Revolutionary Layer Transfer Technology to High-Volume Manufacturing with EVG®850 NanoCleave™ System
Infrared laser cleave technology enables ultra-thin-layer transfer from silicon substrates with nanometer precision, revolutionizing 3D integration for advanced packaging and transistor scaling ST. FLORIAN, Austria, Dec. 8, 2023 /PRNewswire/ — EV Group (EVG), a leading supplier of wafer bondi
Pozelimab Emerging Drug Insight and Market Forecasts, 2019-2032: An Investigational, Fully Human mAb Designed to Block Complement Factor C5 and Prevent the Destruction of Red Blood Cells
DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “Pozelimab Emerging Drug Insight and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about pozelimab for paroxysmal nocturnal hemoglobinuria (PNH)
Best Bank Innovations: How Online Banking is Tailored for the Digital Age by 3D Chess Media
Online banks utilize data analytics and machine learning to enhance customer experience. This personalized approach reshapes financial interactions in the digital age. LAS VEGAS, Dec. 7, 2023 /PRNewswire/ — In today’s rapidly digitizing world, the banking sector isn’t left behind.
Px HealthCare Unveils First-of-its-Kind, Real World Evidence Study Using OWise Breast Cancer Patient Support App
LONDON, Dec. 7, 2023 /PRNewswire/ — Px HealthCare (Px), the digital health company behind the clinically-validated OWise cancer patient support app, announced today the presentation of a first-of-its-kind Real World Evidence (RWE) study at the San Antonio Breast Cancer Symposium (SABCS). The s
Mallinckrodt Announces FDA Clearance of the INOmax® EVOLVE™ DS Delivery System and Approval of the INOmax® (nitric oxide) Mini-Cylinder
– Company’s next generation nitric oxide delivery system combines mini-cylinder technology, automation, integration, and interaction into one device1 – – The INOmax EVOLVE DS also earned recognition from the Human Factors and Ergonomics Society (HFES) for this year’s innovativ
United Kingdom Construction Market Trend Analysis and Forecast 2023-2027 – Average Construction Material Price Index Rose by 5.3% YoY in H1 2023
DUBLIN, Dec. 7, 2023 /PRNewswire/ — The “United Kingdom (UK) Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast, 2023-2027″ report has been added to ResearchAndMarkets.com’s offering. The construction industry in the UK is forecast to sh
